{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T04:19:56Z","timestamp":1744777196027,"version":"3.40.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T00:00:00Z","timestamp":1744675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pregnancy Childbirth"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Preterm birth is the most important cause of neonatal morbidity and mortality. Clinical guidelines recommend assessment of risk of preterm birth and implementation of interventions to reduce preterm birth risk through dedicated preterm birth clinics. We hypothesized that a two-tier preterm birth clinic pathway can safely manage women at the highest risk of preterm birth while reducing intervention for women at moderate risk of preterm birth. We aimed to test this hypothesis by evaluating risk factors, management, and outcomes of women attending a two-tier preterm birth prevention service.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We conducted a retrospective cohort study of women who gave birth between January and June 2021 at a tertiary hospital in Oxford, UK. We included two cohorts: women attending a Cervical Screening Clinic and women attending a Preterm Birth Clinic, and we also reviewed all cases of births before 34 weeks over that time period. At the initial midwife appointment at 8\u201310 weeks\u2019 gestation, risk factors for preterm birth were assessed. Pregnant women with moderate risk factors (previous preterm birth at 32<jats:sup>+\u20090<\/jats:sup> \u2212\u200933<jats:sup>+\u20096<\/jats:sup> weeks, previous preterm prelabour rupture of membranes (PPROM) at 32<jats:sup>+\u20090<\/jats:sup> \u2212\u200933<jats:sup>+\u20096<\/jats:sup> weeks, previous LLETZ \/ cone biopsy, known abnormal uterus, previous caesarean section at 10\u00a0cm dilatation, and multiple pregnancy) were referred to the Cervical Screening Clinic for a cervical length scan by a sonographer. Pregnant women with major risk factors (previous preterm birth at 16<jats:sup>+\u20090<\/jats:sup> \u2212\u200931<jats:sup>+\u20096<\/jats:sup> weeks, previous PPROM at less than 32<jats:sup>+\u20090<\/jats:sup> weeks, radical trachelectomy, previous cervical cerclage) as well as those with a cervix\u2009&lt;\u200925\u00a0mm at any scan were referred to the Preterm Birth Clinic for a cervical length scan and counselling by a specialist obstetrician. Detailed information on risk factors, management, and perinatal outcomes were collected from case notes and analysed.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>189 women attended the Cervical Screening Clinic: 79.1% had a moderate risk factor for preterm birth, 100% had a cervical length scan, 7% had a short cervix and 4.2% received an intervention. All 196 infants were live born, with overall preterm birth rates of 14.8% at &lt;\u200937 weeks, 3.1% at &lt;\u200932 weeks, and 0% at &lt;\u200928 weeks. The spontaneous live preterm birth rates were 9.7% at &lt;\u200937 weeks, 2.6% at &lt;\u200932 weeks and 0% at &lt;\u200928 weeks. 79 women attended the Preterm Birth Clinic: 87.3% had a major risk factor for preterm birth, 100% had\u2009\u2265\u20091 cervical length scan, 41.3% had a short cervix, 78.1% received vaginal progesterone, and 39% had a cervical cerclage. Overall preterm birth rates were 33.8% at &lt;\u200937 weeks, 10.3% at &lt;\u200932 weeks and 4.4% at &lt;\u200928 weeks. Spontaneous live preterm birth rates were 22.1% at &lt;\u200937 weeks, 7.4% at &lt;\u200932 weeks, and 2.9% at &lt;\u200928 weeks. 115 women gave birth to 130 babies before 34 weeks: 80% had no major risk factor for preterm birth, 29% had a cervical length scan and less than 15% had an intervention. Over 90% had a live birth, but the neonatal death rate was high (8.5%).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Women with moderate risk factors for preterm birth seen in the Cervical Screening Clinic had low rates of intervention and good perinatal outcomes. Most women with major risk factors were appropriately referred and managed by the Preterm Birth Clinic. This two-tier preterm birth prevention service therefore appears safe and effective.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12884-025-07538-8","type":"journal-article","created":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T09:52:16Z","timestamp":1744710736000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of a two-tier preterm birth prevention service in a tertiary hospital in the United Kingdom: a retrospective cohort study"],"prefix":"10.1186","volume":"25","author":[{"given":"Michael","family":"Shea","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carolina","family":"Longo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"LeThanh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Natasja","family":"Vandepitte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joris","family":"Hemelaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,4,15]]},"reference":[{"key":"7538_CR1","unstructured":"National Institute of Health and Care Excellence. Preterm labour and birth NICE guideline [NG25]. 2015. Available from: www.nice.org.uk\/guidance\/ng25"},{"key":"7538_CR2","unstructured":"NHS England. Saving babies\u2019 lives: version 3. A care bundle for reducing perinatal mortality. 2023. Available from: https:\/\/www.england.nhs.uk\/long-read\/saving-babies-lives-version-3\/"},{"key":"7538_CR3","unstructured":"UK Preterm Clinical Network. Reducing Preterm Birth: Guidelines for Commissioners and Providers. 2019. https:\/\/www.tommys.org\/sites\/default\/files\/2021-03\/reducing preterm birth guidance 19.pdf"},{"key":"7538_CR4","doi-asserted-by":"crossref","unstructured":"Ferrero DM, Larson J, Jacobsson B, Renzo GC, Di, Norman JE, Martin JN et al. Cross-Country individual participant analysis of 4.1 million Singleton births in 5 countries with very high human development index confirms known associations but provides no biologic explanation for 2\/3 of all preterm births. PLoS ONE. 2016;11(9):e0162506.","DOI":"10.1371\/journal.pone.0162506"},{"key":"7538_CR5","doi-asserted-by":"crossref","unstructured":"Dawes L, Groom K, Jordan V, Waugh J. The use of specialised preterm birth clinics for women at high risk of spontaneous preterm birth: A systematic review. BMC Pregnancy and Childbirth. 2020; 20(1):58.","DOI":"10.1186\/s12884-020-2731-7"},{"issue":"5","key":"7538_CR6","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/uog.5323","volume":"31","author":"JMG Crane","year":"2008","unstructured":"Crane JMG, Hutchens D. Transvaginal sonographic measurement of cervical length to predict preterm birth in asymptomatic women at increased risk: A systematic review. Ultrasound Obstet Gynecol. 2008;31(5):579\u201387.","journal-title":"Ultrasound Obstet Gynecol"},{"key":"7538_CR7","doi-asserted-by":"crossref","unstructured":"Berghella V, Saccone G. Cervical assessment by ultrasound for preventing preterm delivery. Cochrane Database of Systematic Reviews. 2019.","DOI":"10.1002\/14651858.CD007235.pub4"},{"key":"7538_CR8","doi-asserted-by":"crossref","unstructured":"Alfirevic Z, Stampalija T, Medley N. Cervical stitch (cerclage) for preventing preterm birth in singleton pregnancy. Cochrane Database of Systematic Reviews. 2017.","DOI":"10.1002\/14651858.CD008991.pub3"},{"issue":"10280","key":"7538_CR9","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1016\/S0140-6736(21)00217-8","volume":"397","author":"EPPPIC Group","year":"2021","unstructured":"EPPPIC Group. Evaluating progestogens for preventing preterm birth international collaborative (EPPPIC): meta-analysis of individual participant data from randomised controlled trials. Lancet. 2021;397(10280):1183\u201394.","journal-title":"Lancet"},{"key":"7538_CR10","doi-asserted-by":"crossref","unstructured":"Care A, Nevitt SJ, Medley N, Donegan S, Good L, Hampson L et al. Interventions to prevent spontaneous preterm birth in women with singleton pregnancy who are at high risk: Systematic review and network meta-analysis. BMJ. 2022; 376:e064547.","DOI":"10.1136\/bmj-2021-064547"},{"key":"7538_CR11","doi-asserted-by":"crossref","unstructured":"Abdel-Aleem H, Shaaban OM, Abdel-Aleem MA, Aboelfadle Mohamed A. Cervical Pessary for preventing preterm birth in Singleton pregnancies. Cochrane Database Syst Reviews. 2022;12(12):CD014508.","DOI":"10.1002\/14651858.CD014508"},{"key":"7538_CR12","doi-asserted-by":"crossref","unstructured":"Klebanoff MA, Schuit E, Lamont RF, Larsson PG, Odendaal HJ, Ugwumadu A et al. Antibiotic treatment of bacterial vaginosis to prevent preterm delivery: systematic review and individual participant data meta-analysis. 37, Paediatric and Perinatal Epidemiology. 2023;239\u201351.","DOI":"10.1111\/ppe.12947"},{"issue":"11","key":"7538_CR13","doi-asserted-by":"publisher","first-page":"1361","DOI":"10.1111\/1471-0528.15173","volume":"125","author":"N Medley","year":"2018","unstructured":"Medley N, Poljak B, Mammarella S, Alfirevic Z. Clinical guidelines for prevention and management of preterm birth: a systematic review. BJOG. 2018;125(11):1361\u20139.","journal-title":"BJOG"},{"issue":"4","key":"7538_CR14","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/1471-0528.12512","volume":"121","author":"AN Sharp","year":"2014","unstructured":"Sharp AN, Alfirevic Z. Provision and practice of specialist preterm labour clinics: A UK survey of practice. BJOG. 2014;121(4):417\u201321.","journal-title":"BJOG"},{"issue":"1","key":"7538_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/AOG.0000000000001195","volume":"127","author":"J van \u2019t Hooft","year":"2016","unstructured":"van \u2019t Hooft J, Duffy JMN, Daly M, Williamson PR, Meher S, Thom E, et al. A core outcome set for evaluation of interventions to prevent preterm birth. Obstet Gynecol. 2016;127(1):49\u201358.","journal-title":"Obstet Gynecol"},{"issue":"7","key":"7538_CR16","first-page":"1178","volume":"129","author":"AH Shennan","year":"2022","unstructured":"Shennan AH, Story L; Royal College of Obstetricians, Gynaecologists. Cervical cerclage: green-top guideline no. 75. BJOG. 2022;129(7):1178\u2013210.","journal-title":"Green-top Guideline 75 BJOG"},{"issue":"1","key":"7538_CR17","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/uog.19073","volume":"52","author":"KH Nicolaides","year":"2018","unstructured":"Nicolaides KH, Wright D, Syngelaki A, Wright A, Akolekar R. Fetal medicine foundation fetal and neonatal population weight charts. Ultrasound Obstet Gynecol. 2018;52(1):44\u201351.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"7538_CR18","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1159\/000526538","volume":"87","author":"E Soto","year":"2022","unstructured":"Soto E, Huntley ES, Hernandez-Andrade E. Weekly differences in the prevalence of a short cervix at 18 + 0 to 23 + 6 weeks of gestation in pregnant women with and without a history of preterm delivery. Gynecol Obstet Invest. 2022;87(5):299\u2013304.","journal-title":"Gynecol Obstet Invest"},{"issue":"4","key":"7538_CR19","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.ajog.2016.02.002","volume":"214","author":"LA Temming","year":"2016","unstructured":"Temming LA, Durst JK, Tuuli MG, Stout MJ, Dicke JM, Macones GA, et al. Universal cervical length screening: implementation and outcomes. Am J Obstet Gynecol. 2016;214(4):523.e1-523.e8.","journal-title":"Am J Obstet Gynecol"},{"issue":"11","key":"7538_CR20","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1080\/14767058.2017.1421166","volume":"32","author":"R Navathe","year":"2019","unstructured":"Navathe R, Saccone G, Villani M, Knapp J, Cruz Y, Boelig R, et al. Decrease in the incidence of threatened preterm labor after implementation of transvaginal ultrasound cervical length universal screening. J Maternal-Fetal Neonatal Med. 2019;32(11):1853\u20138.","journal-title":"J Maternal-Fetal Neonatal Med"},{"issue":"3","key":"7538_CR21","doi-asserted-by":"publisher","first-page":"e3651","DOI":"10.1016\/j.ajog.2015.12.020","volume":"214","author":"M Son","year":"2016","unstructured":"Son M, Grobman WA, Ayala NK, Miller ES. A universal mid-trimester transvaginal cervical length screening program and its associated reduced preterm birth rate. Am J Obstet Gynecol. 2016;214(3):e3651\u20135.","journal-title":"Am J Obstet Gynecol"},{"key":"7538_CR22","unstructured":"UK National Screening Committee (UK N S C). Screening for preterm birth in asymptomatic, low-risk women. 2020."},{"key":"7538_CR23","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1016\/j.ejogrb.2024.11.005","volume":"303","author":"EVJ van Limburg Stirum","year":"2024","unstructured":"van Limburg Stirum EVJ, Pilarski N, de Boer MA, Pajkrt E, Oudijk MA, van \u2019t Hooft J. Variation between countries for routine transvaginal cervical length measurement and interventions to prevent preterm birth. Eur J Obstet Gynecol Reprod Biol. 2024;303:266\u201371.","journal-title":"Eur J Obstet Gynecol Reproductive Biology"},{"issue":"15","key":"7538_CR24","doi-asserted-by":"publisher","first-page":"2628","DOI":"10.1080\/14767058.2018.1555816","volume":"33","author":"TL Tran","year":"2020","unstructured":"Tran TL, Jwala S, Terenna C, McGregor A, Das A, Baxter JK, et al. Evaluation of additive effect of quantitative fetal fibronectin to cervical length for prediction of spontaneous preterm birth among asymptomatic high-risk women. J Maternal-Fetal Neonatal Med. 2020;33(15):2628\u201334.","journal-title":"J Maternal-Fetal Neonatal Med"},{"issue":"3","key":"7538_CR25","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1002\/uog.20401","volume":"55","author":"HA Watson","year":"2020","unstructured":"Watson HA, Seed PT, Carter J, Hezelgrave NL, Kuhrt K, Tribe RM, et al. Development and validation of predictive models for QUiPP app V.2: tool for predicting preterm birth in asymptomatic high-risk women. Ultrasound Obstet Gynecol. 2020;55(3):348\u201356.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"8","key":"7538_CR26","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1111\/aogs.12405","volume":"93","author":"L Danti","year":"2014","unstructured":"Danti L, Zonca M, Barbetti L, Lojacono A, Marini S, Cappello N, et al. Prophylactic oral Nifedipine to reduce preterm delivery: A randomized controlled trial in women at high risk. Acta Obstet Gynecol Scand. 2014;93(8):802\u20138.","journal-title":"Acta Obstet Gynecol Scand"},{"issue":"8","key":"7538_CR27","first-page":"1370","volume":"33","author":"J Ivandic","year":"2020","unstructured":"Ivandic J, Care A, Goodfellow L, Poljak B, Sharp A, Roberts D, et al. Cervical Pessary for short cervix in high risk pregnant women: 5 years experience in a single centre. J Maternal-Fetal Neonatal Med. 2020;33(8):1370\u20136.","journal-title":"J Maternal-Fetal Neonatal Med"},{"issue":"6","key":"7538_CR28","doi-asserted-by":"publisher","first-page":"e7391","DOI":"10.1016\/j.ajog.2015.12.007","volume":"214","author":"N Stricker","year":"2016","unstructured":"Stricker N, Timmesfeld N, Kyvernitakis I, Goerges J, Arabin B. Vaginal progesterone combined with cervical Pessary: A chance for pregnancies at risk for preterm birth? Am J Obstet Gynecol. 2016;214(6):e7391\u201373910.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"7538_CR29","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.ajog.2016.11.1037","volume":"216","author":"JP Newnham","year":"2017","unstructured":"Newnham JP, White SW, Meharry S, Lee HS, Pedretti MK, Arrese CA, et al. Reducing preterm birth by a statewide multifaceted program: an implementation study. Am J Obstet Gynecol. 2017;216(5):434\u201342.","journal-title":"Am J Obstet Gynecol"},{"key":"7538_CR30","doi-asserted-by":"crossref","unstructured":"Carlisle N, Care A, Anumba DOC, Dalkin S, Sandall J, Shennan AH. How are hospitals in England caring for women at risk of preterm birth in 2021? The influence of National guidance on preterm birth care in England: a National questionnaire. BMC Pregnancy Childbirth. 2023;23(1).","DOI":"10.1186\/s12884-023-05388-w"},{"issue":"6","key":"7538_CR31","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1111\/1471-0528.15549","volume":"126","author":"A Care","year":"2019","unstructured":"Care A, Ingleby L, Alfirevic Z, Sharp A. The influence of the introduction of National guidelines on preterm birth prevention practice: UK experience. BJOG. 2019;126(6):763\u20139.","journal-title":"BJOG"},{"issue":"7","key":"7538_CR32","doi-asserted-by":"publisher","first-page":"928","DOI":"10.3109\/14767058.2010.535872","volume":"24","author":"LA Bolt","year":"2011","unstructured":"Bolt LA, Chandiramani M, De Greeff A, Seed PT, Kurtzman J, Shennan AH. The value of combined cervical length measurement and fetal fibronectin testing to predict spontaneous preterm birth in asymptomatic high-risk women. J Maternal-Fetal Neonatal Med. 2011;24(7):928\u201332.","journal-title":"J Maternal-Fetal Neonatal Med"},{"issue":"4","key":"7538_CR33","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1016\/j.ajog.2015.10.148","volume":"214","author":"AL Turitz","year":"2016","unstructured":"Turitz AL, Bastek JA, Purisch SE, Elovitz MA, Levine LD. Patient characteristics associated with 17-alpha hydroxyprogesterone caproate use among a high-risk cohort. Am J Obstet Gynecol. 2016;214(4):536.e1-536.e5","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"7538_CR34","doi-asserted-by":"publisher","first-page":"e3201","DOI":"10.1016\/j.ajog.2011.01.011","volume":"204","author":"TA Manuck","year":"2011","unstructured":"Manuck TA, Henry E, Gibson J, Varner MW, Porter TF, Jackson GM, et al. Pregnancy outcomes in a recurrent preterm birth prevention clinic. Am J Obstet Gynecol. 2011;204(4):e3201\u20136.","journal-title":"Am J Obstet Gynecol"},{"issue":"4","key":"7538_CR35","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1111\/ajo.12610","volume":"57","author":"K Hughes","year":"2017","unstructured":"Hughes K, Sim S, Roman A, Michalak K, Kane S, Sheehan P. Outcomes and predictive tests from a dedicated specialist clinic for women at high risk of preterm labour: A ten year audit. Aust N Z J Obstet Gynaecol. 2017;57(4):405\u201311.","journal-title":"Aust N Z J Obstet Gynaecol"},{"issue":"9","key":"7538_CR36","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1515\/jpm-2021-0020","volume":"49","author":"W Jin","year":"2021","unstructured":"Jin W, Hughes K, Sim S, Shemer S, Sheehan P. The contemporary value of dedicated preterm birth clinics for high-risk Singleton pregnancies: 15-year outcomes from a leading maternal centre. J Perinat Med. 2021;49(9):1048\u201357.","journal-title":"J Perinat Med"},{"issue":"6","key":"7538_CR37","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1111\/ajo.13176","volume":"60","author":"L Dawes","year":"2020","unstructured":"Dawes L, Restall A, de Sousa J, Pole JR, Waugh J, Groom K. The experience and outcomes of a specialised preterm birth clinic in new Zealand. Aust N Z J Obstet Gynaecol. 2020;60(6):904\u201313.","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"7538_CR38","doi-asserted-by":"crossref","unstructured":"McDougall ARA, Hastie R, Goldstein M, Tuttle A, Ammerdorffer A, G\u00fclmezoglu AM et al. New medicines for spontaneous preterm birth prevention and preterm labour management: landscape analysis of the medicine development pipeline. BMC Pregnancy Childbirth. 2023;23(1):525.","DOI":"10.1186\/s12884-023-05842-9"}],"container-title":["BMC Pregnancy and Childbirth"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07538-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12884-025-07538-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12884-025-07538-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T09:52:24Z","timestamp":1744710744000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpregnancychildbirth.biomedcentral.com\/articles\/10.1186\/s12884-025-07538-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,15]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["7538"],"URL":"https:\/\/doi.org\/10.1186\/s12884-025-07538-8","relation":{},"ISSN":["1471-2393"],"issn-type":[{"value":"1471-2393","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,15]]},"assertion":[{"value":"26 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed as part of a service evaluation using routinely collected data. The study was registered with the Oxford University Hospitals NHS Foundation Trust audit department. The study was reviewed by the Joint Research Office of Oxford University Hospitals NHS Foundation Trust and Oxford University, and was deemed not to need formal ethical approval as it falls under the category of a service evaluation study. This is in line with the guidance from the United Kingdom NHS Health Research Authority () stating that explicit consent for use of patient information for clinical audit and service improvement purposes is not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not Applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"452"}}